tiprankstipranks
Novartis AG Takes Major Stake in MorphoSys
Company Announcements

Novartis AG Takes Major Stake in MorphoSys

Morphosys Ag (MOR) has released an update.

Don't Miss our Black Friday Offers:

MorphoSys AG has announced a significant change in shareholding, with Novartis AG acquiring a new total of 91.04% of voting rights as of June 19, 2024. The acquisition marks a substantial increase from the previous notification, indicating a major shift in the company’s ownership structure. This strategic move by Novartis signals a strong commitment to MorphoSys AG’s future.

For further insights into MOR stock, check out TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistIs MOR a Buy, Before Earnings?
TipRanks Auto-Generated NewsdeskMorphoSys AG Finalizes Delisting After Novartis Acquisition
TheFlyOxford Biomedica CFO Stuart Paynter to step down, Lucinda Crabtree to succeed
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App